A Study to Evaluate the Effects of SAGE-718 in Participants With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (AD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The primary purpose of this study is to evaluate the effect of SAGE-718 on cognitive performance in participants with Alzheimer\'s Disease.
Epistemonikos ID: a8658c4159307a9c43ab8630c0c1fb50d95beb4e
First added on: May 14, 2024